LEP and multiple sclerosis: The prevalence of autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), multiple sclerosis (MS) and type 1 diabetes mellitus (T1D), is increasing in affluent countries and associates with serum leptin levels [119].